Topics

Articles

Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs

In first year, the product has six of Top 20 companies as clients

New study finds payer cost savings for patients with comorbidities

Zephyr Health adds Referral and Segment Analytics to its Illuminate data service

EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs

Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs

More unusual gyrations as Mylan attempts to quell uprising against its pricing policies

Good Neighbor and Health Mart franchises trade top positions

Presidential politicking adds momentum  to the growing backlash, and not just for Mylan